Several factors are involved in YAP nuclear translocation and activation, including the inhibition of YAP phosphorylation by LATS [109], CLDN6-ZO2-YAP interactions [110], and the binding of CLDN18 with YAP [111], which together lead to a poor prognosis in gastric cancer [112]. This evidence concerns the gene YAP1 and gastric cancer.